AtomVie Global Radiopharma is a global contract development and manufacturing organization.
AtomVie Global Radiopharma has raised $90.0M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
AtomVie Global Radiopharma's investors include Avego Management.
AtomVie Global Radiopharma is headquartered in Hamilton, Canada.
AtomVie Global Radiopharma is a global contract development and manufacturing organization.
AtomVie Global Radiopharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AtomVie Global Radiopharma — Funding & Investors." VCBacked, June 1, 2023, https://www.vcbacked.co/company/atomvie-global-radiopharma. Accessed September 30, 2026.
VCBacked. (2023). AtomVie Global Radiopharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/atomvie-global-radiopharma
{{cite web |title=AtomVie Global Radiopharma — Funding & Investors |url=https://www.vcbacked.co/company/atomvie-global-radiopharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated